Growth Hormone for Osteoporosis Pseudoglioma Syndrome

Summary

Osteoporosis pseudoglioma (OPPG) syndrome is a rare autosomal recessive condition of childhood osteoporosis and congenital blindness for which new treatments are needed. We have found that body fat is increased in OPPG and muscle mass is reduced. We hypothesize that growth hormone therapy will improve muscle mass and bone strength in OPPG.

Timeline

Start

2013-12

Primary completion

2015-12

Completion

2015-12

Outcome

Outcome not reported

Stopped (Business): “it was never started because it was never funded”

Drugs

Indications